The Association between the Use of Proton Pump Inhibitors and the Risk of Hypomagnesemia in a National Cohort of Veteran Patients with HIV
Open Access
- 1 January 2019
- journal article
- research article
- Published by SAGE Publications in Journal of the International Association of Providers of AIDS Care (JIAPAC)
- Vol. 18
Abstract
Objectives: To examine the risk of hypomagnesemia of HIV-positive patients adherent to proton pump inhibitors (PPIs). Methods: A cohort study utilizing the Veterans Affairs Informatics and Computing Infrastructure was conducted on patients with (1) a complete antiretroviral therapy, (2) a serum magnesium measure during the study period, and (3) adherent to PPIs. Statistical analyses evaluated baseline characteristics between cohorts and a Cox proportional hazards model evaluating the association of hypomagnesemia while adjusting for baseline covariates. Results: A total of 6047 patients met the study inclusion criteria, 329 patients in the PPI cohort and 5718 patients in the non-PPI cohort. The stratified Cox proportional hazards model results revealed that the risk of hypomagnesemia for the PPI cohort is 3.16 times higher compared to the non-PPI cohort (adjusted hazard ratio = 3.16, 95% confidence interval = 2.56-3.9). Conclusions: Proton pump inhibitors medication usage in HIV-positive patients is associated with a higher risk of hypomagnesemia compared to non-PPI patients.Keywords
This publication has 28 references indexed in Scilit:
- Proton pump inhibitors and hypomagnesemia: a rare but serious complicationKidney International, 2013
- Proton-pump inhibitor use is associated with low serum magnesium concentrationsKidney International, 2013
- HIV/AIDS-Associated Opportunistic Protozoal DiarrheaAIDS Research and Human Retroviruses, 2013
- Systematic review: hypomagnesaemia induced by proton pump inhibitionAlimentary Pharmacology & Therapeutics, 2012
- Uses of proton pump inhibitors and hypomagnesemiaPharmacoepidemiology and Drug Safety, 2012
- Pharmacy Adherence Measures to Assess Adherence to Antiretroviral Therapy: Review of the Literature and Implications for Treatment MonitoringClinical Infectious Diseases, 2011
- Medication AdherenceCirculation, 2009
- Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapiesAIDS, 2007
- Concomitant use of gastric acid‐reducing agents is frequent among HIV‐1‐infected patients receiving protease inhibitor‐based highly active antiretroviral therapy*HIV Medicine, 2007
- Proton-Pump Inhibitors and Hypomagnesemic HypoparathyroidismNew England Journal of Medicine, 2006